Advertisement

Topics

CORRECTING and REPLACING Stratus Pharmaceuticals Responds to Misinformation In the Aftermath of FDA Consent Agreement

21:38 EDT 19 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Second paragraph, second sentence of release should read: For example, Alberto Hoyo was not the President or CEO of Sonar Products Inc. when the incidents that gave rise to the FDA enforcement action took place. (instead of For ...

Other Sources for this Article

Carlton Fields, PA
Olga Suarez Vieira, 305-539-7379
Attorney for Stratus Pharmaceuticals
ovieira@carltonfields.com

NEXT ARTICLE

More From BioPortfolio on "CORRECTING and REPLACING Stratus Pharmaceuticals Responds to Misinformation In the Aftermath of FDA Consent Agreement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...